Solution Spotlight: InConcert for pre-launch
As health and life sciences companies prepare for market entry, the pre-launch window has become one of the most complex phases of the commercialisation journey. Decisions made during this period shape readiness across markets, influence early uptake, and set the trajectory for launch performance. Yet, teams are often forced to make these decisions with incomplete visibility, as commercial, medical, and analytics teams work from different data sources, timelines, and perspectives.
InConcert is Inizio’s connected intelligence solution built specifically for this pivotal moment. The solution brings together engagement data, field insight, and clinical indicators to help teams see how readiness is taking shape and where action is needed. By connecting signals that have traditionally lived in silos, InConcert gives launch leaders a shared foundation for planning, prioritisation, and cross-functional alignment. Launch leaders can then explore that foundation using natural-language prompts to test assumptions and understand implications.
Explore how InConcert supports stronger pre-launch decision-making, addressing the themes that matter most for commercial foresight ahead of launch.
What problem or status quo deficiency are you solving?
For years, pre-launch teams across commercial, medical, and analytics functions have worked with fragmented intelligence, with critical signals sitting in separate systems. One captures omnichannel engagement, another holds field insights, and others track clinical signals. These gaps create blind spots and add friction to decision-making when launch planning depends on inputs from multiple functions, making it harder to plan, prioritise, and act on emerging opportunities and risks. Over time, this can affect launch momentum and limit early visibility into potential risks.
Inizio designed InConcert to address this challenge by bringing pre-launch intelligence into one integrated solution – giving teams a shared view of readiness and enabling them to interpret early signals, anticipate challenges, and make more confident, forward-looking decisions that drive stronger launch outcomes.
What new innovations does your solution bring to bear on these challenges?
InConcert introduces a new approach to pre-launch decision-making – uniting omnichannel, field, and clinical insights into a single, connected solution. Its modular, large language model (LLM)-powered engine supports intuitive natural-language queries. For launch teams, this means faster identification of high-value audiences and clearer visibility into channels with untapped potential. Because the models are purpose-built for life sciences, they reflect the scientific nuance and regulatory sensitivity of this domain, along with the complexity of bringing therapies to market. The solution delivers immediate contextualised answers that previously required time-consuming data pulls from multiple systems – accelerating decision cycles. InConcert extends this capability by drawing from Inizio’s extensive historical datasets, including 25mn+ hours of healthcare professional engagement signals and 200+ structured brand meeting analyses that deepen the accuracy and relevance of its modelling.
This is Intelligent Commercialization in action – Inizio connects expert insight with the power of data, technology, and AI so teams can move from early signals to decisions they can stand behind. Domain experts across Inizio shape and validate the models, helping ensure insights are practical, credible, and ready to apply in real-world launch environments.
How does your solution work?
InConcert operates on a connected intelligence architecture built around four complementary data layers that continuously inform one another:
- The omnichannel intelligence layer reveals how messages resonate across digital, virtual, and in-person touchpoints, highlighting areas of growing interest and unmet need.
- The field performance layer translates qualitative medical and commercial interactions into measurable signals that show how engagement shapes perception and influence.
- Clinical foresight links real-world evidence, treatment patterns, and therapeutic indicators to expected commercial outcomes, helping teams identify strengths and potential barriers to adoption.
- Predictive engagement models then use these inputs to forecast behavioural shifts, resource needs, and channel impact.
By bringing these four core data layers into one solution, InConcert supports rapid scenario exploration, informed prioritisation, and direct movement from insight to action. This shared working space reduces handoffs and delays, enabling clients to align teams more quickly during a phase when decisions often span multiple functions and markets. As planning needs evolve, the architecture supports a connected workflow that allows teams to incorporate new signals faster, without disrupting existing processes, and without sacrificing accuracy.
What makes your solution stand out in the market?
InConcert stands out through its combination of proprietary data depth and AI designed for life sciences, reinforced by direct access to Inizio’s expertise. It brings engagement patterns, field insights, and clinical behaviour data together, so teams gain a more complete view of launch readiness and where action is needed. The solution provides a scalable foundation that supports expansion across markets and therapy areas, while remaining flexible enough to work alongside existing systems. Teams can typically activate pilots within 10 to 14 weeks through rapid deployment, depending on scope and configuration, enabling early value without disrupting current operations. InConcert’s human-plus-AI model remains a defining strength, with insights shaped and validated by Inizio specialists to ensure outputs reflect therapeutic nuance and real-world launch demands. Together, these capabilities create a differentiated solution for teams preparing to introduce new therapies to patients.
How does your solution improve the experience for the end user?
To simplify the daily work of launch leaders, the solution brings the intelligence they need into a single, intuitive view. Instead of piecing together insights from multiple dashboards or waiting on manual analysis, teams can ask direct questions and receive contextualised answers in moments. Working from the same intelligence foundation reduces time spent reconciling differing views and frees teams to focus on coordinated planning and execution. This experience reduces cognitive load, shortens planning cycles, and keeps teams focused on priorities that matter most.
Designed around real client workflows, the solution supports a client-first approach across interface and functionality. By organising scattered information into a dependable view of launch progress, InConcert helps teams focus on the actions that matter most.
About Inizio
Inizio is a leading commercialization partner that provides tailored, innovative solutions to help health and life sciences companies globally with their clinical development and commercialization journeys, maximizing patient access.
With more than 10,500 employees across five business units, Medical, Ignite, Evoke, Engage and Biotech, Inizio support clients through every pivotal moment of their asset lifecycle, from discovery to post-launch, offering specialized expertise across all therapeutic areas to maximize asset potential and impact, and enhance treatment outcomes.
For more information visit: www.inizio.com
